Roche Lung Cancer Drug Shows Promise in Phase 3 Trial
By David Sachs Roche said Friday that its Alecensa drug demonstrated the ability to reduce recurrence of lung cancer for patients in the early stage of the disease.…
Read more Roche Lung Cancer Drug Shows Promise in Phase 3 Trial